JPRN-jRCT1050210015RecruitingUnknown
A platform study for developing diagnostic / treatment strategy for COVID-19 patients - COVID-19 platform study
Muto Manabu0 sites100 target enrollmentStarted: May 6, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- >= 18age old to ot applicable (—)
Inclusion Criteria
- •1) Definite COVID-19 patients
- •2) Male or female >= 18 years of age
- •3) Under close observation or in-patient hosptalization
- •4) Signed written informed consent approved by the relevant Independent Ethics Committee
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Not Applicable
Establishment of clinical research platform based on dementia cohortKCT0005516Samsung Medical Center300
Active, not recruiting
Phase 1
A Pilot study to investigate the cardiac effect and pharmacokinetics of potential combination treatments for COVID-19EUCTR2020-002314-40-ATMedizinische Universität Wien; Universitätsklinik für Klinische Pharmakologie16
Not yet recruiting
Unknown
Smart tool to diagnose tropical feversCTRI/2024/04/065866Manipal Academy of Higher Education
Recruiting
Not Applicable
Applicability of Positron Emission Tomography using Gallium-68 labelled Fibroblast Activating Protein Inhibitor for the diagnosis, staging and treatment of pancreatic cancer.Cancer - PancreaticPancreatic CancerACTRN12621000935831Royal Brisbane & Women's Hospital62
Active, not recruiting
Phase 1
Alginate encapsulated Stem Cell Transplantation study for Corneal diseases.CTRI/2021/07/035034Hyderabad Eye Research Foundation